MicroRNAs and Cardiovascular Disease

Author(s): Zhiguo Wang

DOI: 10.2174/978160805184711001010127

miRNA Interference Approaches for Cardiovascular Disease

Pp: 127-135 (9)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

miRNA interference (miRNAi) is a new concept that I proposed for the development of strategies and technologies to manipulate the function, stability, biogenesis, or expression of miRNAs and as such it indirectly interferes with expression of protein-coding mRNAs. This chapter aims to give an implicitly detailed introduction to some of the miRNAi strategies and technologies developed so far. The fundamental mechanism of miRNA regulation of gene expression is miRNA:mRNA interaction or binding. A key to interfere with miRNA actions is to disrupt the miRNA:mRNA interaction. In order to achieve this aim, one can either manipulate miRNAs or mRNAs to alter the miRNA:mRNA interaction. For miRNAs, one can either mimic miRNA actions to enhance the miRNA:mRNA interaction or to inhibit miRNAs to break the miRNA:mRNA interaction. Both gain-offunction and loss-of-function technologies are necessary tools for understanding miRNAs. The miRNAi technologies have opened up new opportunities for creative and rational designs of a variety of combinations integrating varying nucleotide fragments for various purposes and provided exquisite tools for functional analysis related to identification and characterization of targets of miRNAs and their functions in gene controlling program. In addition, the miRNAi technologies also offer the strategies and tools for designing new agents for gene therapy of human disease.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books